These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Verapamil SR 240 mg as a contribution to compliance in long-term treatment of hypertension. Reinfrank J; Eckardt A; Hahn KJ Bibl Cardiol; 1987; (42):156-60. PubMed ID: 3307756 [No Abstract] [Full Text] [Related]
44. [The role of calcium antagonists in the treatment of arrhythmias in myocardial ischemia]. Sannino A; Calabretta G; Raddi G; Santamaria G; Russo C Minerva Med; 1980 Mar; 71(8):597-8. PubMed ID: 7360390 [No Abstract] [Full Text] [Related]
45. [Cross double-blind study with verapamil x placebo in ischemic heart disease with an ergometric test]. Ribeiro JM; Sadi J; Barros FA Arq Bras Cardiol; 1984 Aug; 43(2):139-42. PubMed ID: 6398044 [No Abstract] [Full Text] [Related]
46. [Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil]. Pozenel H Med Welt; 1981 Jun; 32(24):988-92. PubMed ID: 7253907 [No Abstract] [Full Text] [Related]
47. [Exercise capacity of coronary heart disease patients in long-term follow-up with gallopamil in comparison with premedication with verapamil]. Reiterer W Z Kardiol; 1989; 78 Suppl 5():63-8. PubMed ID: 2517157 [TBL] [Abstract][Full Text] [Related]
48. [Beta receptor antagonists--pharmacologic characteristics and mechanism of action in cardiovascular diseases]. Langnickel R; Bluth R Z Arztl Fortbild (Jena); 1984; 78(7):255-61. PubMed ID: 6145258 [No Abstract] [Full Text] [Related]
50. [Verapamil in ischemic pain and arrhythmia]. Waris E Duodecim; 1972; 88(20):1223-32. PubMed ID: 5076303 [No Abstract] [Full Text] [Related]
51. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension]. Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612 [TBL] [Abstract][Full Text] [Related]
52. Calcium channel antagonists--cardiovascular therapy for the eighties? Burgess CD N Z Med J; 1986 May; 99(802):362-3. PubMed ID: 3464877 [No Abstract] [Full Text] [Related]
53. [Effect of antihypertensive drug treatment on the incidence of cardiovascular morbidity and mortality in mild arterial hypertension]. Tomov I Vutr Boles; 1985; 24(6):39-47. PubMed ID: 3913145 [No Abstract] [Full Text] [Related]
54. [The effect of isoptin on changes in the concentration of potassium in the bodies of patients with hypertension and coronary insufficiency]. Bogoliubov VM; Lyskova MN Kardiologiia; 1972 Aug; 12(8):124-6. PubMed ID: 4642623 [No Abstract] [Full Text] [Related]
55. [Verapamil in the treatment of patients with coronary insufficiency]. Savenkov PM; Doscicin VL; Zarov EI; Arsakuni RO Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1287+. PubMed ID: 4098328 [No Abstract] [Full Text] [Related]
56. Clinical trial of a new coronary dilator (verapamil hydrochloride) in ischemic heart disease. Husain SA; Saksena HC; Kothari RP; Marothi PS Indian J Med Sci; 1973 Aug; 27(8):596-600. PubMed ID: 4770896 [No Abstract] [Full Text] [Related]
58. [Basic treatment of hemodynamic and metabolic disorders in cardiovascular disease]. Gilbert JC Sem Hop Ther; 1975 Nov; 51(9):463-6. PubMed ID: 1198120 [No Abstract] [Full Text] [Related]
59. Cardiovascular disease in the elderly. Wenger NK Cardiology; 1987; 74(4):310-5. PubMed ID: 3621275 [No Abstract] [Full Text] [Related]
60. [Roentgenometry with the utilization of a standard measure and fluorograms]. Sadof'ev AI Vestn Rentgenol Radiol; 1968; 43(2):69-75. PubMed ID: 5739381 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]